B2B TECHNOLOGY for Heart Failure

TODAY THERE IS AN EMPHASIS TO IMPROVE QUALITY OF LIFE (QOL) AMONG HF PATIENTS WHILE MANAGING SYMPTOMS, DEFINING THE CLINICAL AND ECONOMIC GOALS.

26 M

HF patients worldwide

6M in U.S.

$ 108 B

Economic burden

$32B in U.S.

74 %

HF patients with

comorbidities

PARTNERSHIPS

We partner with medical device manufacturers to incorporate our technology.


Our team has decades of experience with hardware design, signal processing, algorithm development, and regulatory approval of medical devices.


Audicor technology is designed and developed under ISO 13485 QMS controls.

medicine, cooperation, hand

USE MODELS

wearable

Wearable

sketch 3

Implantable

sketch1 jpeg

Daily Monitoring

sketch 2 jpeg

Hospital

TEAM

PB(Copy)

Peter Bauer
PRESIDENT

AA(Copy)

Alan Andresen
VP ENGINEERING

TW(Copy)

Tim Wheeler
VP STRATEGY AND COMMERCIALIZATION

PA(Copy)

Patti Arand
DIRECTOR RESEARCH AND ALGORITHMS

GH(Copy)

Gregg Harris
DIRECTOR QUALITY AND REGULATORY